UnknownPHASE1, PHASE2NCT05214014

Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Principal Investigator
Andrei Hancharou, Dr
the Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Intervention
Autologous Regulatory Т-cells(biological)
Enrollment
30 enrolled
Eligibility
18-80 years · All sexes
Timeline
2022 – 2023

Study locations (1)

Collaborators

Belarusian State Medical University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05214014 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis →

← Back to all trials